<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499561</url>
  </required_header>
  <id_info>
    <org_study_id>A symptomatic bacteriuria</org_study_id>
    <nct_id>NCT03499561</nct_id>
  </id_info>
  <brief_title>a Smptomatic Bacteriuria in Pregnancy</brief_title>
  <official_title>a Symptomatic Bacteriuria in Pregnant Females</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asymptomatic bacteriuria (ASB) is defined as the presence of at least 105 colony-forming
      units (CFU)/ml of 1 or 2 bacterial species in clean-voided midstream urine sample from an
      individual without symptoms of UTI
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ASB is common in women and increases in prevalence with age and/or sexual activity, due to
      short urethra, pregnancy, easy contamination of urinary tract with fecal flora

      The pregnant women are two times more commonly affected than age matched non pregnant
      females. This is due to urinary stasis due to progesterone effect in pregnancy in addition to
      different morphological and physiological changes occurring during pregnancy The prevalence
      of ASB is about 3 times higher in diabetic women (ranging from 15% to 30%) than in
      non-diabetic women (less than 10%)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 17, 2018</start_date>
  <completion_date type="Anticipated">September 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participants who will discovered to have bacteriuria</measure>
    <time_frame>within 4 weeks</time_frame>
    <description>Incidence of asymptomatic bacteriuria among pregnant females.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Bacteriuria in Pregnancy</condition>
  <arm_group>
    <arm_group_label>pregnant women in first Trimester</arm_group_label>
    <description>A urine sample will be taken from pregnant women before 14 weeks of pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregnant women in second Trimester</arm_group_label>
    <description>A urine sample will be taken from pregnant women from 14 weeks +1 day till 28 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregnant women in third Trimester</arm_group_label>
    <description>A urine sample will be taken from pregnant women from 28 weeks +1 day till 40 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>urine analysis</intervention_name>
    <description>Intervention is (urine analysis ): of a mid stream urine sample will be taken</description>
    <arm_group_label>pregnant women in first Trimester</arm_group_label>
    <arm_group_label>pregnant women in second Trimester</arm_group_label>
    <arm_group_label>pregnant women in third Trimester</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant non-symptomatic females.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Pregnant females 2. Non-symptomatic females.

        Exclusion Criteria:

          -  1. Patients taking antibiotics in the last two weeks. 2. Symptomatic UTI. 3. Suspected
             urinary tract abnormalities. 4. Urinary catheterization. 5. Renal dialysis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant females with no symptoms</gender_description>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy</last_name>
    <role>Principal Investigator</role>
    <affiliation>Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud Alalfy, M.s.c</last_name>
    <phone>01002611058</phone>
    <email>mahmoudalalfy@ymail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Algazeerah</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mahmoud Alalfy, master</last_name>
      <phone>+201002611058</phone>
      <email>mahmoudalalfy@ymail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ahmed Elgazzar, M.D</last_name>
      <phone>+201014005959</phone>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud Alalfy, master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2018</study_first_submitted>
  <study_first_submitted_qc>April 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aljazeera Hospital</investigator_affiliation>
    <investigator_full_name>Mahmoud Alalfy</investigator_full_name>
    <investigator_title>Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteriuria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The research will be published after finishing results</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

